How did TXG's Q4 earnings surprise impact its annual performance?

10x Genomics (TXG) experienced a significant decline in its annual net income, with a cumulative loss of $255.1 million over the past three years, despite a total revenue of $516.41 million for the same period. The Q4 earnings surprise of -0.09, which represents a negative deviation from the expected earnings per share, indicates that TXG's performance in this quarter was below market expectations. This negative surprise likely contributed to the company's overall financial struggles, as it reflects ongoing challenges or operational inefficiencies that have not yet been fully addressed. |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |TXG|TXG.O|10x Genomics|2022 Q1|-267.180330707298|-4.2413E7|185| |TXG|TXG.O|10x Genomics|2022 Q2|-483.2247557003258|-6.4458E7|185| |TXG|TXG.O|10x Genomics|2022 Q3|-144.097606429445|-4.1914E7|185| |TXG|TXG.O|10x Genomics|2022 Q4|6.6887094151444515|-1.7215E7|185| |TXG|TXG.O|10x Genomics|2023 Q1|-19.64963572489567|-5.0747E7|185| |TXG|TXG.O|10x Genomics|2023 Q2|3.171057122467343|-6.2414E7|185| |TXG|TXG.O|10x Genomics|2023 Q3|-121.84950135992747|-9.2986E7|185| |TXG|TXG.O|10x Genomics|2023 Q4|-184.35666569851875|-4.8952E7|185| |TXG|TXG.O|10x Genomics|2024 Q1|-18.13309161132678|-5.9949E7|185| |TXG|TXG.O|10x Genomics|2024 Q2|39.281251001377896|-3.7897E7|185| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |TXG|TXG.O|10x Genomics|2022 Q1|8.197805728541594|1.14496E8|185| |TXG|TXG.O|10x Genomics|2022 Q2|-1.0643807945304813|1.14609E8|185| |TXG|TXG.O|10x Genomics|2022 Q3|4.6090488998140415|1.31072E8|185| |TXG|TXG.O|10x Genomics|2022 Q4|8.849717829025291|1.56232E8|185| |TXG|TXG.O|10x Genomics|2023 Q1|17.28357322526551|1.34285E8|185| |TXG|TXG.O|10x Genomics|2023 Q2|28.10425010252249|1.46819E8|185| |TXG|TXG.O|10x Genomics|2023 Q3|17.2210693359375|1.53644E8|185| |TXG|TXG.O|10x Genomics|2023 Q4|17.760125966511342|1.83979E8|185| |TXG|TXG.O|10x Genomics|2024 Q1|5.005026622482035|1.41006E8|185| |TXG|TXG.O|10x Genomics|2024 Q2|4.280781097814316|1.53104E8|185|